Phosphate Binders May Lower Death Risk
Phosphate binder use is associated with a reduced death risk and slower progression of renal disease in non-dialysis CKD patients, according to investigators at ASN’s Renal Week 2009.
Renal Week 2009 Hyperphosphatemia
Drugs Not Equal in Phosphorus Lowering
Lanthanum carbonate treatment achieved greater reductions in serum phosphorus than did sevelamer hydrochloride in a study of hemodialysis patients with elevated serum phosphorus that was presented at ASN’s Renal Week 2009.
Study: Combo Could Be a Promising New Option for Hyperphosphatemia
Combination tablets containing calcium acetate and magnesium carbonate (CaMg) may be at least as effective as sevelamer hydrochloride tablets in lowering serum phosphorus, a study found.
Ferric Citrate Works as Well as Other Phosphate Binders
Ferric citrate is at least as potent as other phosphate binders and it raises serum sodium bicarbonate levels, according to a pilot study of hemodialysis (HD) patients requiring high doses of phosphate binders.
Vitamin D Plus a Phosphorus Binder Improves Survival in Dialysis Patients
A study of Japanese dialysis patients demonstrated that a combination of oral vitamin D and a phosphorus binder is associated with lower mortality.
Higher Phosphorus Levels, Atherosclerosis Linked
Higher phosphorus levels are associated with peripheral atherosclerosis and arterial stiffness, independent of traditional risk factors for cardiovascular disease (CVD), according to a study.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...